Figure 3.
Cardiomyocyte proliferation with etomoxir (ETO) treatment. (A) Cardiomyocytes in DNA synthesis-phase were detected by using Click-iT EdU Alexa Fluor (red) and co-immunostaining with antibody against cTnT (green) on tissue cross sections. Quantification of EdU+cTnT+ cells as percentage of total cTnT+ cells analyzed per field. Arrows point to EdU+cTnT+ cells. (B) Cardiomyocytes in mitotic phase were detected and quantified by immunostaining for PH3 (red) and cTnT (green) on tissue longitudinal sections. Arrows point to PH3+cTnT+ cells. (C) Cardiomyocyte proliferation were visualized by co-immunostaining of heart sections (P5) for Ki67 (red) and cTnT (green). Graph on the right showing quantification of Ki67+cTnT+ as percentage of total cTnT+ cells analyzed per field. Arrows point to Ki67+cTnT+ cells. (D) Percentage of mononuclear (Mono-CM) and binuclear (Bi-CM) cardiomyocytes in the heart ventricles of infant mice at P5. (E) Total number of cardiomyocytes in heart ventricles in infant mice at P5. (F) Immunostaining and quantification of TUNEL (green) and DAPI (blue) in P5 heart sections. Arrows point to TUNEL+ nuclei. (G) Expression of Bax and Bcl2 by qRT-PCR analysis of the mRNA of isolated heart ventricles at P5 (n = 4 per group). P value was calculated using Student’s t-test (A–C, E–G) and two-way ANOVA (D).